Eugene A. Bauer, Director at Aevi Genomic Medicine, Inc. (GNMX), bought 19,841 shares at $1.26 ($25K) on 2017-10-17, disclosed to the SEC on 2017-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DERM | SELL | 2018-03-02 | $13K | — | Filing → |
| DERM | SELL | 2018-02-02 | $86K | — | Filing → |
| DERM | SELL | 2018-01-04 | $81K | — | Filing → |